Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > Return on Equity %

Arena Pharmaceuticals Return on Equity % Chart (ARNA)

Arena Pharmaceuticals annual/quarterly Return on Equity % from 2000 to 2018.
  • Arena Pharmaceuticals Return on Equity % for the quarter ending September 09, 2018 was -25.18 a -6.61% increase of 1.66 year over year
  • Arena Pharmaceuticals Return on Equity % for the last 12 months ending September 09, 2018 was -29.77 a -160.15% increase of 47.68 year over year
  • Arena Pharmaceuticals Annual Return on Equity % for 2017 was -77.45 a 66.19% decrease of -51.26 from 2016
  • Arena Pharmaceuticals Annual Return on Equity % for 2016 was -26.19 a -738.05% increase of 193.28 from 2015
  • Arena Pharmaceuticals Annual Return on Equity % for 2015 was -219.47 a 60.39% decrease of -132.53 from 2014
Other Margins & Efficiency Metrics:
  • Arena Pharmaceuticals EBITDA Margin for the quarter ending December 12, 2017 was $-82m a -245.61% increase of 200m year over year
  • Arena Pharmaceuticals Return on Capital % for the quarter ending September 09, 2018 was -14.88 a 16.87% decrease of -2.51 year over year
View Chart On Koyfin

Quarterly ARNA Return on Equity % Data

09/2018-25.18
06/2018-22.28
03/2018-31.48
12/2017-26.84
09/2017-93.85
06/2017-174.12
03/2017-269.06
09/2016-566.07
06/2016-425.42
03/2016-189.22

Annual ARNA Return on Equity % Data

2017-77.45
2016-26.19
2015-219.47
2014-86.94
2013-20.40
2012-156.55
2011-241.17
2010-161.12
2009-159.42
2008-93.55